Clinical Trial Update: A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) [Phase 1, Phase 2]

View source ↗

Summary

CHAMP-1 is a Phase 1/2 study evaluating RNK05047 in adults with advanced solid tumors or diffuse large B-cell lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Solid Tumor

Drugs mentioned

• RNK05047

Snippet

Sponsor: Ranok Therapeutics (Hangzhou) Co., Ltd. | Conditions: Advanced Solid Tumor, DLBCL | Phase 1, Phase 2 | Status: RECRUITING